The first structure-activity relationships for a benzothiazole scaffold acting as an antagonist at GPR35 is presented. Analogues were designed based on a lead compound that was previously determined to have selective activity as a GPR35 antagonist. The synthetic route was modular in nature to independently explore the role of the middle and both ends of the scaffold. The activities of the analogues illustrate the importance of all three segments of the compound.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5335871 | PMC |
| http://dx.doi.org/10.1016/j.bmcl.2016.12.012 | DOI Listing |
Publication Analysis
Top Keywords
structure-activity relationships
8
relationships benzothiazole
8
benzothiazole gpr35
4
gpr35 antagonists
4
antagonists structure-activity
4
benzothiazole scaffold
4
scaffold acting
4
acting antagonist
4
antagonist gpr35
4
gpr35 presented
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!